on-invasive diagnosis of urinary bladder cancer

Not Applicable

• Conditions: Diagnostic workup in patients with macroscopic haematuria; Cancer; Urothelial carcinoma, macroscopic haematuria

• Registration Number: ISRCTN17940603
• Lead Sponsor: Västra Götaland Regional Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-04
• Last Update Posted: 15 May 2023
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 1516

Inclusion Criteria

1. Aged =50 years
2. Referred to participating centres for evaluation of macroscopic haematuria according to standardised care pathway
3. Able to give signed informed consent

Exclusion Criteria

1. History of urothelial carcinoma
2. Unable to give voided urine sample/has urine catheter

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnosis of urinary bladder cancer within one year of enrolment collected retrospectively from medical records at 1 year after enrolment

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures